OasisLMS

While diet recommendations have seemed to go back and forth in weight loss trials in terms of carbohydrates and fats, high protein recommendations appear to have been consistently recommended. With a unique combination of evidence-based science and humor, Professor Gardner will share his perspective across multiple weight loss diet trials that despite a range of designs and protein recommendations, protein almost always ends up at 20% of calories – and he can’t explain why.

1. After participating in the webinar, learners will be able to describe the important difference between overall macronutrient distribution vs. subtypes of macronutrients (i.e., quality) in weight loss diet trials.

2. After this webinar, learners will be better equipped to counsel their patients on nutrition and apply what they’ve learned about macronutrient distribution in diet trials in their advice for patients attempting to lose weight.

The Obesity Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Obesity Society designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME Activity ID 202573213

Date of Release: September 1, 2024
Date of Termination: December 31, 2026

No commercial support was received for this activity.

Christopher Gardner, PhD: Researcher relationship with Beyond Meat (Food*)

Monica Agarwal, MD: No Relevant Financial Relationships

Johnny Figueroa, PhD: No Relevant Financial Relationships

Leslie Golden, MD, MPH: No Relevant Financial Relationships

Valentina Ivezaj, PhD: No Relevant Financial Relationships

Aaron Kelly, PhD: No Relevant Financial Relationships

Robert Kushner, MD: Advisor Relationship with Novo Nordisk (Pharmaceuticals), WW (Medical Food and Weight Management*), and Eli Lilly (Pharmaceuticals) Consultant relationship with Altimmune (Pharmaceuticals), Pfizer Inc. (Pharmaceuticals), and Boehringer Ingelheim (Pharmaceuticals)

Magdalena Pasarica, MD, PhD: No Relevant Financial Relationships Jonathan Purnell, MD Consultation Relationship with Novo Nordisk (Pharmaceuticals), Boehringer Ingelheim (Pharmaceuticals), and Luciole (Pharmaceuticals)

Amanda Velazquez, MD: Advisor relationship with WW (Medical Food and Weight Management*) and Intellihealth (Weight Management*) Consultation Relationship with Novo Nordisk (Pharmaceuticals)

Denise Wilfley, PhD: No Relevant Financial Relationships

No members of the TOS CME Oversight Committee, charged with the resolution of all relevant conflicts of interest, had any relevant financial relationships while serving on the committee.

1. Landry MJ, Ward CP, Cunanan KM, Fielding-Singh P, Crimarco A, Gardner CD. Switching diets after 6-months does not result in renewed weight loss: a secondary analysis of a 12-month crossover randomized trial. Sci Rep. 2024 Apr 29;14(1):9865. doi: 10.1038/s41598-024-60547-z. PMID: 38684815; PMCID: PMC11058757.

2. Hauser ME, Hartle JC, Landry MJ, Fielding-Singh P, Shih CW, Qin F, Rigdon J, Gardner CD. Association of dietary adherence and dietary quality with weight loss success among those following low-carbohydrate and low-fat diets: a secondary analysis of the DIETFITS randomized clinical trial. Am J Clin Nutr. 2024 Jan;119(1):174-184. doi: 10.1016/j.ajcnut.2023.10.028. Epub 2023 Nov 4. PMID: 37931749; PMCID: PMC10808819.
3. Gardner CD, Crimarco A, Landry MJ, Fielding-Singh P. Nutrition Study Design Issues-Important Issues for Interpretation. Am J Health Promot. 2020 Nov;34(8):951-954. doi: 10.1177/0890117120960580d. PMID: 33076690; PMCID: PMC7935659.